Our study also had a low prevalence of sputum and salivary anti-PAD4 positivity, which limits our ability to identify all possible associations between clinical characteristics and sputum or salivary anti-PAD4 antibodies in RA patients. Here, PADI4 is linked to rheumatoid arthritis.